Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Angiodynamics, Inc. clinical trials
The registry lists 24 studies whose lead sponsor is Angiodynamics, Inc. or one of 1 company grouped under it. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 11, 2026.
Keep track of what changes. Save the Angiodynamics, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Angiodynamics, Inc..
- Angiodynamics, Inc.22 studiesSame company
Something wrong?
- Eximo Medical Ltd.2 studies →Acquired — became part of Angiodynamics, Inc., Oct 2, 2019 · source ↗
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 24 of 24.
- Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)Not yet recruitingNCT07640776Not applicable
- Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and EffectivenessRecruitingNCT07280247Not applicable
- Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective EndocarditisNot yet recruitingNCT07282002Not applicable
- Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in EuropeNot yet recruitingNCT07472439Not applicable
- Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty AloneRecruitingNCT06777901Phase 4
- International Study on Treatment of Liver (HCC) Patients With IRENot yet recruitingNCT07192731Not applicable
- International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRENot yet recruitingNCT07191548Not applicable
- Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 SystemRecruitingNCT06697314Not applicable
- Pivotal Study of the NanoKnife System for the Ablation of Prostate TissueCompletedNCT04972097Not applicable
- Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery DiseaseCompletedNCT04229563
- A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerActive, not recruitingNCT03899636Phase 3
- A Registry Study of NanoKnife IRE for Stage 3 Pancreatic CancerActive, not recruitingNCT03899649
- Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary EmbolismCompletedNCT05318092Not applicable
- Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk PatientsStatus unknownNCT01972867Not applicable
- Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD TreatmentCompletedNCT02556255Not applicable
Sponsor listed in the registry: Eximo Medical Ltd. · First submitted before Eximo Medical Ltd. became part of Angiodynamics, Inc.
- SeCure Endovenous Laser Treatment StudyCompletedNCT02215369Not applicable
- Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PADCompletedNCT03157531Not applicable
Sponsor listed in the registry: Eximo Medical Ltd. · First submitted before Eximo Medical Ltd. became part of Angiodynamics, Inc.
- The PROOF Study: The PICC Related Obstruction Of Flow StudyTerminatedNCT01921114Not applicable
- Initial Experience With the AngioVac Venous Drainage CannulaCompletedNCT02775565
- NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic CancerCompletedNCT01369420Phase 2
- Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)TerminatedNCT01064895
- Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)CompletedNCT01078415Not applicable
- Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous VeinWithdrawnNCT01173419Not applicable
- Radiofrequency Ablation of Pulmonary Tumors Response EvaluationCompletedNCT00690703Phase 2